525 related articles for article (PubMed ID: 19877980)
1. Methylphenidate combined with aripiprazole in children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder: a randomized crossover trial.
Zeni CP; Tramontina S; Ketzer CR; Pheula GF; Rohde LA
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):553-61. PubMed ID: 19877980
[TBL] [Abstract][Full Text] [Related]
2. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
Masi G; Gagliano A; Siracusano R; Berloffa S; Calarese T; Ilardo G; Pfanner C; Magazù A; Cedro C
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):120-5. PubMed ID: 22375853
[TBL] [Abstract][Full Text] [Related]
4. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
Scheffer RE; Kowatch RA; Carmody T; Rush AJ
Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial.
Tramontina S; Zeni CP; Pheula GF; de Souza CK; Rohde LA
CNS Spectr; 2007 Oct; 12(10):758-62. PubMed ID: 17934380
[TBL] [Abstract][Full Text] [Related]
6. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
[TBL] [Abstract][Full Text] [Related]
7. A Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Clinical Trial of ORADUR-Methylphenidate for Treating Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Huang YS; Yeh CB; Chen CH; Shang CY; Gau SS
J Child Adolesc Psychopharmacol; 2021 Apr; 31(3):164-178. PubMed ID: 33395356
[No Abstract] [Full Text] [Related]
8. Attention-deficit/hyperactivity disorder and comorbid subsyndromal depression: what is the impact of methylphenidate on mood?
Golubchik P; Kodesh A; Weizman A
Clin Neuropharmacol; 2013; 36(5):141-5. PubMed ID: 24045603
[TBL] [Abstract][Full Text] [Related]
9. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
[TBL] [Abstract][Full Text] [Related]
10. Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder.
Findling RL; Short EJ; McNamara NK; Demeter CA; Stansbrey RJ; Gracious BL; Whipkey R; Manos MJ; Calabrese JR
J Am Acad Child Adolesc Psychiatry; 2007 Nov; 46(11):1445-53. PubMed ID: 18049294
[TBL] [Abstract][Full Text] [Related]
11. Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorder.
Chang K; Nayar D; Howe M; Rana M
J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):547-51. PubMed ID: 19877979
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
[TBL] [Abstract][Full Text] [Related]
13. A randomized crossover clinical study showing that methylphenidate-SODAS improves attention-deficit/hyperactivity disorder symptoms in adolescents with substance use disorder.
Szobot CM; Rohde LA; Katz B; Ruaro P; Schaefer T; Walcher M; Bukstein O; Pechansky F
Braz J Med Biol Res; 2008 Mar; 41(3):250-7. PubMed ID: 18327433
[TBL] [Abstract][Full Text] [Related]
14. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
Pan PY; Fu AT; Yeh CB
J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole in children with attention-deficit/hyperactivity disorder.
Findling RL; Short EJ; Leskovec T; Townsend LD; Demeter CA; McNamara NK; Stansbrey RJ
J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):347-54. PubMed ID: 18759644
[TBL] [Abstract][Full Text] [Related]
17. Buspirone versus methylphenidate in the treatment of children with attention- deficit/ hyperactivity disorder: randomized double-blind study.
Mohammadi MR; Hafezi P; Galeiha A; Hajiaghaee R; Akhondzadeh S
Acta Med Iran; 2012; 50(11):723-8. PubMed ID: 23292622
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.
Keck PE; Calabrese JR; McQuade RD; Carson WH; Carlson BX; Rollin LM; Marcus RN; Sanchez R;
J Clin Psychiatry; 2006 Apr; 67(4):626-37. PubMed ID: 16669728
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.
Levin FR; Evans SM; Brooks DJ; Garawi F
Drug Alcohol Depend; 2007 Feb; 87(1):20-9. PubMed ID: 16930863
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
Suppes T; Eudicone J; McQuade R; Pikalov A; Carlson B
J Affect Disord; 2008 Apr; 107(1-3):145-54. PubMed ID: 17904226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]